Under the shade of a spreading peepul tree, just 26 km from Varanasi, a few miles off NH31, Nayak Verma, the pradhan (headman) of Dhaura Hara village, watches as Prem Chand Maurya, an Arogya Health Shikshak (educator).
As the initiative completes its 10th year in India this year, Jawed Zia, Country President, Novartis India, says Arogya Parivar is a sustainable...
Global drug major Novartis has invested, expanded its research & development (R&D) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio.
Find contacts at Novartis for media and journalist inquiries
This site is intended for a local audience